NCT06909175

Brief Summary

Liver transplantation is usually associated with hemodynamic instability. TEE allows for a real time monitoring of cardiac structures and has become a standard of care for liver transplant patients. Society of cardiovascular anaesthesia and American society of anaesthesiologists recommends use of TEE in non-cardiac surgery patients with hemodynamic instability. Also, society for advancement of transplant anaesthesia (SATA) has suggested that TEE usage in cases of liver transplant is safe, effective and improves outcomes. TEE can also provide vital information relating to non-cardiac structures including liver, spleen, kidneys, portal vein, hepatic vein and other major vessels. As of now standard protocol is to do the transabdominal doppler for the assessment of portal vein after the liver graft implantation. Hence, the aim of our study is to compare the transesophageal echocardiography and transabdominal Doppler for assessing portal vein in living donor liver transplantation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 3, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

April 5, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2025

Completed
Last Updated

June 26, 2025

Status Verified

June 1, 2025

Enrollment Period

1 month

First QC Date

March 27, 2025

Last Update Submit

June 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To compare the portal vein flow velocity using transesophageal echocardiography and transabdominal Doppler during live donor liver transplant surgery.

    intraoperative period

Secondary Outcomes (1)

  • any TEE related complication

    intraoperative period

Interventions

Portal vein velocities were measured using TEE and intraoperative doppler in patients undergoing living donor liver transplantation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chronic liver disease

You may qualify if:

  • All patients who have undergone Live donor liver transplant, Age \> 18 years

You may not qualify if:

  • Required data is not available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ILBS

Delhi, 110070, India

Location

MeSH Terms

Interventions

Echocardiography, Transesophageal

Intervention Hierarchy (Ancestors)

EchocardiographyCardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Gaurav Sindwani, MD

    Institute of Liver and Biliary Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 27, 2025

First Posted

April 3, 2025

Study Start

April 5, 2025

Primary Completion

May 5, 2025

Study Completion

June 5, 2025

Last Updated

June 26, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations